Cullen Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-4,143
| Closed | -$343K | – | 213 |
|
2024
Q2 | $343K | Sell |
4,143
-1,554
| -27% | -$129K | ﹤0.01% | 178 |
|
2024
Q1 | $486K | Sell |
5,697
-347
| -6% | -$29.6K | 0.01% | 150 |
|
2023
Q4 | $517K | Sell |
6,044
-1,078
| -15% | -$92.2K | 0.01% | 159 |
|
2023
Q3 | $638K | Sell |
7,122
-4,038
| -36% | -$362K | 0.01% | 125 |
|
2023
Q2 | $950K | Sell |
11,160
-381
| -3% | -$32.4K | 0.01% | 200 |
|
2023
Q1 | $955K | Buy |
11,541
+2,130
| +23% | +$176K | 0.01% | 187 |
|
2022
Q4 | $740K | Sell |
9,411
-6,256
| -40% | -$492K | 0.01% | 148 |
|
2022
Q3 | $1.16M | Sell |
15,667
-317
| -2% | -$23.5K | 0.01% | 183 |
|
2022
Q2 | $1.04M | Hold |
15,984
| – | – | 0.01% | 187 |
|
2022
Q1 | $1.01M | Hold |
15,984
| – | – | 0.01% | 185 |
|
2021
Q4 | $848K | Buy |
15,984
+2,805
| +21% | +$149K | 0.01% | 194 |
|
2021
Q3 | $930K | Sell |
13,179
-136
| -1% | -$9.6K | 0.01% | 172 |
|
2021
Q2 | $887K | Buy |
+13,315
| New | +$887K | 0.01% | 180 |
|